Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Patients with inflammatory bowel disease (IBD) are at significantly increased risk of
colorectal cancer (CRC), principally resulting from the pro-neoplastic effects of chronic …

Colorectal cancer (CRC) is the third most common cancer and the fourth most common
cause of cancer mortality worldwide. Colitis-associated colorectal cancer (CAC) is a subtype …

Scope Urolithins are bioactive metabolites produced by the gut microbiota from ellagitannins
(ETs) and ellagic acid (EA). We investigated whether urolithins could be detected in colon …

Mutations are a critical driver of cancer initiation. While extensive studies have focused on
exposure-induced mutations, few studies have explored the importance of tissue physiology …

Abstract Background and Aims The association between inflammatory bowel disease [IBD]
and cancer remains poorly defined in Asian populations. Therefore, we conducted a …

Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the
gastrointestinal (GI) tract, and currently no curative treatment is available. Mangiferin, a …

Patients with long-standing inflammatory bowel disease (IBD) have an increased risk of
colorectal cancer (CRC). The association between IBD and CRC is well supported, but …

The management of inflammatory bowel disease (IBD) has changed since the mid‐1990s
(eg, use of thiopurines/anti‐TNFα agents, improved surveillance programs), possibly …

Background: Studies on cancer risk in inflammatory bowel disease (IBD) have yielded
inconsistent results. We conducted a population-based study to determine the risk of cancer …